---
$id: https://graph.org.ai/products/commodity/51371701
$type: Product
source: UNSPSC
code: "51371701"
title: "Narceine"
class: "51371700"
classTitle: "Controlled substance analgesic indole alkaloids"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Narceine

**UNSPSC Code**: 51371701
**Class**: [Controlled substance analgesic indole alkaloids](Controlled substance analgesic indole alkaloids.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist with the molecular formula C23H27NO8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CTT09X2F1M, chemically known as 2,3-dimethoxy-6-((6-(2-dimethylaminoethyl)-2-methoxy-3,4-methylendioxyphenyl)acetyl)benzosaeure but generally known as narceine, which bears US NIH Compound Identifier 8564. European Medicines Agency schedules Narceine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22705. Most nations schedule narceine under HS 29391900 and SITC 54141. As of Q4 2014, NARCEINE remains the US FDA Preferred Term for this commodity. Narceine bears US NLM identifiers UMLS ID C2984004 and NCI Concept Code C91050. SMILES: O1C2C(OC)C(C(CCN(C)C)CC2OC1)CC(=O)C1C(C(OC)C(OC)CC1)C(=O)O.

